| |
|
|
|
Keystone Symposia, Big Sky, Montana
January 6 - 11, 2007
Decades of intense cellular and molecular studies have permitted the identification of many components of the immune system. Studies of the mouse immune system, most particularly through the use of animals with targeted gene inactivation, have permitted remarkable progress in linking these components to specific functions in immunity. In spite of this progress, the study of the human immune system has in general lagged behind that of the mouse. Improvements in technologies, however, now permit a detailed analysis of the altered immune system in human diseases including cancer, allergy, autoimmunity, and infectious diseases. The meeting will emphasize 1) the importance of directly assessing the human immune response and 2) that not all of what we learn in the mouse can be directly translated to humans. To foster interactions between immunologists and pathologists from very different backgrounds, the meeting program includes a wide variety of experts investigating different human diseases that involve alterations of the immune system. Consequently, this meeting is highly likely to contribute to the education of a new generation of immunotherapists.
|
|
|
|
|
|
|
|
Organized by:
|
|
Jacques F. Banchereau, Federica Sallusto and Robert L. Coffman |
|
|
Invited Speakers:
|
|
- Ann Arvin, Stanford University
- Jacques Banchereau, Baylor Institute for Immunology Research
- Albert Bendelac, University of Chicago
- Jeffrey Bluestone, University of California, San Francisco
- Jean-Laurent Casanova, INSERM U 550 Faculté de Médecine Necker
- Andrew Chan, Genentech, Inc.
- Robert Coffman, Dynavax Technologies
- Mary (Nora) Disis, University of Washington Medical Center
- Olivera Finn, University of Pittsburgh School of Medicine
- Brian Foxwell, Imperial College School of Medicine
- Philip Greenberg, University of Washington
- Stefan Kaufmann, Max Planck Institute for Infection Biology-Berlin
- Richard Koup, National Institutes of Health
- Lewis Lanier, University of California, San Francisco
- Antonio Lanzavecchia, Institute for Research in Biomedicine
- Mark Larche, Imperial College London
- Yong-Jun Liu, University of Texas MD Anderson Cancer Center
- Markus Manz, Institute for Research in Biomedicine
- Anna Palucka, Baylor Institute for Immunology Research
- Virginia Pascual, Baylor Institute for Immunology Research
- Jeffrey Ravetch, Rockefeller University
- Maria Roncarolo, San Raffaele Telethon Institute for Gene Therapy
- Federica Sallusto, coffman
- Hergen Spits, Genentech
- Louis Staudt, National Institutes of Health
- Ralph Steinman, Rockefeller University
- Kevin Tracey, North Shore-LIJ Research Institute
- Jürg Tschopp, University of Lausanne
- Cornelia Weyand, Emory University School of Medicine
- George Yancopoulos, Regeneron Pharmaceuticals, Inc.
- Laurence Zitvogel, Institut Gustave Roussy
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Sept. 13, 2006
|
|
|
|
|
|
|
|
Registration:
|
|
Please see website
|
|
|
E-mail:
|
|
info@keystonesymposia.org
|
|
|
|
|
|
|
|
|